keyword
https://read.qxmd.com/read/38445596/biomimetic-hydrogels-promote-pseudoislet-formation-to-improve-glycemic-control-in-diabetic-mice
#21
JOURNAL ARTICLE
Shajun Zhu, Yang Xu, Yuxi Li, Lin Wang, Yan Huang, Jian Wan
Islet or β-cell transplantation is currently considered to be the ideal treatment for diabetes, and three-dimensional (3D) bioprinting of a bionic pancreas with physiological stiffness is considered to be promising for the encapsulation and transplantation of β-cells. In this study, a 5%GelMA/2%AlgMA hybrid hydrogel with pancreatic physiological stiffness was constructed and used for β-cell encapsulation, 3D bioprinting, and in vivo transplantation to evaluate glycemic control in diabetic mice...
March 6, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38412005/accuracy-and-feasibility-of-real-time-continuous-glucose-monitoring-in-critically-ill-patients-after-abdominal-surgery-and-solid-organ-transplantation
#22
JOURNAL ARTICLE
Barbora Voglová Hagerf, Marek Protus, Lenka Nemetova, Milos Mraz, Eva Kieslichova, Eva Uchytilova, Veronika Indrova, Jan Lelito, Peter Girman, Martin Haluzík, Janka Franekova, Veronika Svirlochova, David C Klonoff, Michael A Kohn, Antonin Jabor
OBJECTIVE: Glycemia management in critical care is posing a challenge in frequent measuring and adequate insulin dose adjustment. In recent years, continuous glucose measurement has gained accuracy and reliability in outpatient and inpatient settings. The aim of this study was to assess the feasibility and accuracy of real-time continuous glucose monitoring (CGM) in ICU patients after major abdominal surgery. RESEARCH DESIGN AND METHODS: We included patients undergoing pancreatic surgery and solid organ transplantation (liver, pancreas, islets of Langerhans, kidney) requiring an ICU stay after surgery...
February 27, 2024: Diabetes Care
https://read.qxmd.com/read/38387480/preservation-of-%C3%AE-cells-as-a-therapeutic-strategy-for-diabetes
#23
JOURNAL ARTICLE
Jalal Taneera, Maha M Saber-Ayad
The preservation of pancreatic islet β-cells is crucial in diabetes mellitus, encompassing both type 1 and type 2 diabetes. β-cell dysfunction, reduced mass, and apoptosis are central to insufficient insulin secretion in both types. Research is focused on understanding β-cell characteristics and the factors regulating their function to develop novel therapeutic approaches. In type 1 diabetes (T1D), β-cell destruction by the immune system calls for exploring immunosuppressive therapies, non-steroidal anti-inflammatory drugs, and leukotriene antagonists...
February 22, 2024: Hormone and Metabolic Research
https://read.qxmd.com/read/38362049/the-effect-of-hydroxyethyl-starch-as-a-cryopreservation-agent-during-freezing-of-mouse-pancreatic-islets
#24
JOURNAL ARTICLE
Du Yeon Shin, Jae Suh Park, Han-Sin Lee, Wooyoung Shim, Lauren Jin, Kyo Won Lee, Jae Berm Park, Dong Hyun Kim, Jae Hyeon Kim
Islet transplantation is the most effective treatment strategy for type 1 diabetes. Long-term storage at ultralow temperatures can be used to prepare sufficient islets of good quality for transplantation. For freezing islets, dimethyl sulfoxide (DMSO) is a commonly used penetrating cryoprotective agent (CPA). However, the toxicity of DMSO is a major obstacle to cell cryopreservation. Hydroxyethyl starch (HES) has been proposed as an alternative CPA. To investigate the effects of two types of nonpermeating CPA, we compared 4 % HES 130 and HES 200 to 10 % DMSO in terms of mouse islet yield, viability, and glucose-stimulated insulin secretion ( GSIS)...
July 2024: Biochemistry and Biophysics Reports
https://read.qxmd.com/read/38361234/negative-vaccination-strategies-for-promotion-of-transplant-tolerance
#25
JOURNAL ARTICLE
Matthew J Tunbridge, Xunrong Luo, Angus W Thomson
Organ transplantation requires the use of immunosuppressive medications that lack antigen specificity, have many adverse side effects, and fail to induce immunological tolerance to the graft. The safe induction of tolerance to allogeneic tissue without compromising host responses to infection or enhancing the risk of malignant disease is a major goal in transplantation. One promising approach to achieve this goal is based on the concept of "negative vaccination." Vaccination (or actively acquired immunity) involves the presentation of both a foreign antigen and immunostimulatory adjuvant to the immune system to induce antigen-specific immunity...
February 16, 2024: Transplantation
https://read.qxmd.com/read/38349844/evidence-for-c-peptide-as-a-validated-surrogate-to-predict-clinical-benefits-in-trials-of-disease-modifying-therapies-for-type-1-diabetes
#26
JOURNAL ARTICLE
Esther Latres, Carla J Greenbaum, Maria L Oyaski, Colin M Dayan, Helen M Colhoun, John M Lachin, Jay S Skyler, Michael R Rickels, Simi T Ahmed, Sanjoy Dutta, Kevan C Herold, Marjana Marinac
Type 1 diabetes is a chronic autoimmune disease in which destruction of pancreatic beta cells causes life-threatening metabolic dysregulation. Numerous approaches are envisioned for new therapies, but limitations of current clinical outcome measures are significant disincentives to development efforts. C-peptide, a direct byproduct of proinsulin processing, is a quantitative biomarker of beta cell function that is not cleared by the liver and can be measured in the peripheral blood. Studies of quantitative measures of beta cell function have established a predictive relationship between stimulated C-peptide as a measure of beta cell function and clinical benefits...
February 13, 2024: Diabetes
https://read.qxmd.com/read/38335966/hypoimmune-islets-achieve-insulin-independence-after-allogeneic-transplantation-in-a-fully-immunocompetent-non-human-primate
#27
JOURNAL ARTICLE
Xiaomeng Hu, Kathy White, Chi Young, Ari G Olroyd, Paul Kievit, Andrew J Connolly, Tobias Deuse, Sonja Schrepfer
Allogeneic transplantation of pancreatic islets for patients with difficult-to-control diabetes mellitus is severely hampered by the requirement for continuous immunosuppression and its associated morbidity. We report that allogeneic transplantation of genetically engineered (B2M-/- , CIITA-/- , CD47+ ), primary, hypoimmune, pseudo-islets (p-islets) results in their engraftment into a fully immunocompetent, diabetic non-human primate wherein they provide stable endocrine function and enable insulin independence without inducing any detectable immune response in the absence of immunosuppression...
February 8, 2024: Cell Stem Cell
https://read.qxmd.com/read/38329104/implications-of-endoplasmic-reticulum-stress-and-beta-cell-loss-in-immunodeficient-diabetic-nrg-akita-mice-for-understanding-monogenic-diabetes
#28
JOURNAL ARTICLE
Ahmed M Rashwan, Mohamed M A Abumandour, Ramadan Kandyel, Om Prakash Choudhary, Rofaida Mostafa Soliman, Ashraf El Sharaby, Ahmed G Nomir
BACKGROUND: Immunodeficient mice models have become increasingly important as in vivo models engrafted with human cells or tissues for research. The NOD-Rag1null Ins2Akita Il2rnull (NRG Akita) mice is a model combined with immunodeficient NRG and monogenic diabetes Akita mice that develop spontaneous hyperglycemia with progressive loss of pancreatic insulin-producing beta-cells with age. This model is one of the monogenic diabetic models, which has been providing a powerful platform for transplantation experiments of stem cells-generated human β-cells...
February 8, 2024: International Journal of Surgery
https://read.qxmd.com/read/38318799/on-chip-sorting-of-stem-cell-derived-%C3%AE-cell-clusters-using-traveling-surface-acoustic-waves
#29
JOURNAL ARTICLE
Nikhil Sethia, Joseph Sushil Rao, Zenith Khashim, Anna Marie R Schornack, Michael L Etheridge, Quinn P Peterson, Erik B Finger, John C Bischof, Cari S Dutcher
There is a critical need for sorting complex materials, such as pancreatic islets of Langerhans, exocrine acinar tissues, and embryoid bodies. These materials are cell clusters, which have highly heterogeneous physical properties (such as size, shape, morphology, and deformability). Selecting such materials on the basis of specific properties can improve clinical outcomes and help advance biomedical research. In this work, we focused on sorting one such complex material, human stem cell-derived β cell clusters (SC-β cell clusters), by size...
February 6, 2024: Langmuir: the ACS Journal of Surfaces and Colloids
https://read.qxmd.com/read/38267218/3d-evaluation-of-the-extracellular-matrix-of-hypoxic-pancreatic-islets-using-light-sheet-fluorescence-microscopy
#30
JOURNAL ARTICLE
Matias Ramirez, Estelle Bastien, Heeyoung Chae, Pierre Gianello, Patrick Gilon, Caroline Bouzin
Pancreatic islet transplantation is a promising treatment for type 1 diabetes, but the survival and function of transplanted islets are hindered by the loss of extracellular matrix (ECM) during islet isolation and by low oxygenation upon implantation. This study aimed to evaluate the impact of hypoxia on ECM using a cutting-edge imaging approach based on tissue clearing and 3D microscopy. Human and rat islets were cultured under normoxic (O2 21%) or hypoxic (O2 1%) conditions. Immunofluorescence staining targeting insulin, glucagon, CA9 (a hypoxia marker), ECM proteins (collagen 4, fibronectin, laminin), and E-cadherin (intercellular adhesion protein) was performed on fixed whole islets...
December 31, 2024: Islets
https://read.qxmd.com/read/38235662/firefly-rats-illuminating-the-scientific-community-in-transplantation-research
#31
JOURNAL ARTICLE
Eiji Kobayashi, Yoji Hakamata, Shin Enosawa, Kuang-Ming Shang, Hirotake Komatsu
Fireflies produce light through luciferase-catalyzed reactions involving luciferin, oxygen, and adenosine triphosphate, distinct from other luminescent organisms. This unique feature has revolutionized molecular biology and physiology, serving as a valuable tool for cellular research. Luciferase-based bioluminescent imaging enabled the creation of transgenic animals, such as Firefly Rats. Firefly Rats, created in 2006, ubiquitously express luciferase and have become a critical asset in scientific investigations...
2024: Cell Transplantation
https://read.qxmd.com/read/38213620/hamsab-diet-ameliorates-dysfunctional-signaling-in-pancreatic-islets-in-autoimmune-diabetes
#32
JOURNAL ARTICLE
Valerie Vandenbempt, Sema Elif Eski, Manoja K Brahma, Ao Li, Javier Negueruela, Ylke Bruggeman, Stéphane Demine, Peng Xiao, Alessandra K Cardozo, Nicolas Baeyens, Luciano G Martelotto, Sumeet Pal Singh, Eliana Mariño, Conny Gysemans, Esteban N Gurzov
An altered gut microbiota is associated with type 1 diabetes (T1D), affecting the production of short-chain fatty acids (SCFA) and glucose homeostasis. We previously demonstrated that enhancing serum acetate and butyrate using a dietary supplement (HAMSAB) improved glycemia in non-obese diabetic (NOD) mice and patients with established T1D. The effects of SCFA on immune-infiltrated islet cells remain to be clarified. Here, we performed single-cell RNA sequencing on islet cells from NOD mice fed an HAMSAB or control diet...
January 19, 2024: IScience
https://read.qxmd.com/read/38195859/paracrine-signalling-by-pancreatic-%C3%AE-cells-determines-the-glycaemic-set-point-in-mice
#33
JOURNAL ARTICLE
Jessica L Huang, Mohammad S Pourhosseinzadeh, Sharon Lee, Niels Krämer, Jaresley V Guillen, Naomi H Cinque, Paola Aniceto, Ariana T Momen, Shinichiro Koike, Mark O Huising
While pancreatic β and α cells are considered the main drivers of blood glucose homeostasis through insulin and glucagon secretion, the contribution of δ cells and somatostatin (SST) secretion to glucose homeostasis remains unresolved. Here we provide a quantitative assessment of the physiological contribution of δ cells to the glycaemic set point in mice. Employing three orthogonal mouse models to remove SST signalling within the pancreas or transplanted islets, we demonstrate that ablating δ cells or SST leads to a sustained decrease in the glycaemic set point...
January 9, 2024: Nature metabolism
https://read.qxmd.com/read/38194706/production-of-alginate-macrocapsule-device-for-long-term-normoglycemia-in-the-treatment-of-type-1-diabetes-mellitus-with-pancreatic-cell-sheet-engineering
#34
JOURNAL ARTICLE
Büşra Öncel Duman, Yusufhan Yazir, Zehra Seda Halbutoğulları, Serap Mert, Ahmet Öztürk, Gülçin Gacar, Gökhan Duruksu
Type-1 diabetes mellitus (T1DM) is characterized by damage of beta cells in pancreatic islets. Cell-sheet engineering, one of the newest therapeutic approaches, has also been used to create functional islet systems by creating islet/beta cell-sheets and transferring these systems to areas that require minimally invasive intervention, such as extrahepatic areas. Since islets, beta cells, and pancreas transplants are allogeneic, immune problems such as tissue rejection occur after treatment, and patients become insulin dependent again...
January 9, 2024: Biomedical Materials
https://read.qxmd.com/read/38189586/advancements-and-challenges-in-pancreatic-islet-transplantation-insights-from-the-collaborative-islet-transplant-registry
#35
JOURNAL ARTICLE
Eun Young Lee, Kun-Ho Yoon
No abstract text is available yet for this article.
January 8, 2024: Journal of Diabetes Investigation
https://read.qxmd.com/read/38180833/protocol-for-transplanting-pancreatic-islets-into-the-parametrial-fat-pad-of-female-mice
#36
JOURNAL ARTICLE
Mebrahtu G Tedla, Nathaniel Wright, Esma S Yolcu, Yadong Wang, Haval Shirwan
Although the male epididymal fat pad is an effective site for islet transplantation, females lack this tissue. Here, we present a protocol to assess the parametrial fat pad (PFP) adjacent to the uterine horn in females as an alternative site for islet transplantation. We describe steps for islet isolation from the pancreas, counting, transplantation into PFP, and monitoring for engraftment. Transplantation into PFP is minimally invasive, time efficient, and supports long-term engraftment of syngeneic islets and rejection of allogeneic islets...
January 4, 2024: STAR protocols
https://read.qxmd.com/read/38167219/metabolic-switching-growth-kinetics-and-cell-yields-in-the-scalable-manufacture-of-stem-cell-derived-insulin-producing-cells
#37
JOURNAL ARTICLE
Diepiriye G Iworima, Robert K Baker, Cara Ellis, Chris Sherwood, Lisa Zhan, Alireza Rezania, James M Piret, Timothy J Kieffer
BACKGROUND: Diabetes is a disease affecting over 500 million people globally due to insulin insufficiency or insensitivity. For individuals with type 1 diabetes, pancreatic islet transplantation can help regulate their blood glucose levels. However, the scarcity of cadaveric donor islets limits the number of people that could receive this therapy. To address this issue, human pluripotent stem cells offer a potentially unlimited source for generating insulin-producing cells through directed differentiation...
January 2, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38153636/could-transplantation-into-the-thyroid-gland-benefit-pancreatic-islet-grafting-in-unstable-type-1-diabetes-t1dm-complicated-type-2-diabetes-t2dm-and-patients-with-total-pancreatectomy
#38
JOURNAL ARTICLE
Lodovico Rosato, Eugenia Lavorini, Maurilio Deandrea
BACKGROUND: Insular allograft for unstable type 1 diabetes and autograft in pancreatectomy patients are nowadays considered established procedures with precise indications and predictable outcomes. The clinical outcome of islet transplantation is similar to that of pancreas transplantation, avoiding the complications associated with organ transplantation. OBJECTIVE: We hypothesised that transplantation of islets of Langerhans within an endocrine organ could better promote their engraftment and function...
December 28, 2023: Stem cell reviews and reports
https://read.qxmd.com/read/38146003/subcutaneous-pancreatic-islet-transplantation-without-immunosuppression
#39
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 25, 2023: Nature Biomedical Engineering
https://read.qxmd.com/read/38145318/outcome-after-total-pancreatectomy-with-islet-autotransplantation-a-european-single-center-study
#40
JOURNAL ARTICLE
Klara Fröberg, Asif Halimi, Miroslav Vujasinovic, José Caballero-Corbalan, Urban Arnelo, Ernesto Sparrelid, Olle Korsgren, Johannes-Matthias Löhr, Torbjörn Lundgren, Poya Ghorbani
BACKGROUND AND AIMS: Chronic pancreatitis may cause intractable abdominal pain, with total pancreatectomy sometimes being the last resort. To mitigate the subsequent diabetes, total pancreatectomy can be followed by islet autotransplantation (TP-IAT). The primary aim of this study was to assess the outcomes in patients undergoing TP-IAT at Karolinska University Hospital with respect to safety, postoperative complications, and islet graft function. A secondary aim was to compare liver to skeletal muscle as autotransplantation sites...
December 25, 2023: Scandinavian Journal of Surgery: SJS
keyword
keyword
167546
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.